Hoose Kyri K. Van

Principal Accounting Officer, Turning Point Therapeutics, Inc.

Companies

Dermata Therapeutics, Inc.Chief financial officer Sep 1, 2021 to now¹
Turning Point Therapeutics, Inc.Principal Accounting Officer May 14, 2021 to May 14, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Dermata Therapeutics, Inc. DRMA232,463 shares³$203.3K at $0.87Aug 16, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 16, 2026Granted 102,040 shares of Dermata Therapeutics, Inc.³
Dec 23, 2025Granted 122,549 shares of Dermata Therapeutics, Inc.⁴
Jan 21, 2025Granted 78,741 shares of Dermata Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDermata Therapeutics, Inc., Chief financial officer
2
SEC EDGARTurning Point Therapeutics, Inc., Principal Accounting Officer
3
SEC EDGARDermata Therapeutics, Inc. shares after the filing of Aug 16, 2026
4
SEC EDGARForm 4 filed Dec 29, 2025
5
SEC EDGARForm 4 filed Jan 23, 2025